Publication details

Ranibizumab u pacientů s vlhkou formou věkem podmíněné makulární degenerace - studie SUSTAIN

Title in English Ranibizumab in Patients with Wet Form of Age-related Macular Degeneration - SUSTAIN Study
Authors

KOLÁŘ Petr

Year of publication 2009
Type Article in Periodical
Magazine / Source Farmakoterapie
MU Faculty or unit

Faculty of Medicine

Citation
Field ORL, ophthalmology, stomatology
Keywords SUSTAIN Study; Age-related macular degeneration; Ranibizumab
Description SUSTAIN study investigate effectiveness of ranibizumab in wet form of age-related macular degeneration. It is study IIIb. Together were included 531 subjects. Duration of study was 12 months. Study tested if PRN regiment (pro re nata) leads to reduction of intravitreal application of ranibizumab. Interim analysis demonstrated that average number of applications were 5.3. Visual acuity improve of 5.8 letters on ETDRS chart.

You are running an old browser version. We recommend updating your browser to its latest version.

More info